FDA warns of unusual thigh fracture from use of osteoporosis drugs
Widely used osteoporosis drugs designed to prevent bones from breaking may increase the risk of a rare type of thigh fracture, according to the Food and Drug Administration (FDA). The agency notified consumers and health care workers that all bisphosphonates will now carry a new warning about the fractures on their safety labels.